Concourse Financial Group Securities, Inc. Incyte Corp Transaction History

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 1,212 shares of INCY stock, worth $86,379. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,212

Previous 1,503 19.36%

Holding current value

$86,379

Previous $99,000 16.16%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$65.08 - $83.38 $18,938 - $24,263	-291 Reduced 19.36%	1,212 $83,000
Q3 2024 Oct 10, 2024	SELL	$57.33 - $68.61 $11,007 - $13,173	-192 Reduced 11.33%	1,503 $99,000
Q2 2024 Jul 23, 2024	BUY	$51.18 - $63.75 $8,547 - $10,646	167 Added 10.93%	1,695 $102,000
Q1 2024 Apr 30, 2024	BUY	$56.55 - $66.59 $6,786 - $7,990	120 Added 8.52%	1,528 $87,000
Q4 2023 Feb 07, 2024	BUY	$52.16 - $64.19 $23,732 - $29,206	455 Added 47.74%	1,408 $88,000
Q3 2023 Oct 25, 2023	BUY	$57.77 - $65.93 $17,331 - $19,779	300 Added 45.94%	953 $55,000
Q2 2023 Aug 10, 2023	BUY	$60.95 - $75.51 $9,386 - $11,628	154 Added 30.86%	653 $40,000
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $9,621 - $11,783	137 Added 37.85%	499 $36,000
Q4 2022 Jan 30, 2023	BUY	$67.18 - $84.11 $10,547 - $13,205	157 Added 76.59%	362 $0
Q2 2022 Aug 09, 2022	BUY	$66.18 - $83.18 $5,559 - $6,987	84 Added 69.42%	205 $16,000
Q1 2022 May 09, 2022	SELL	$66.02 - $79.71 $6,602 - $7,970	-100 Reduced 45.25%	121 $10,000
Q4 2021 Feb 07, 2022	BUY	$63.34 - $74.11 $13,998 - $16,378	221 New	221 $16,000
Q3 2021 Nov 09, 2021	SELL	$68.67 - $84.02 $1,373 - $1,680	-20 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$79.87 - $87.53 $137,216 - $150,376	-1,718 Reduced 98.85%	20 $0
Q1 2021 May 13, 2021	BUY	$76.02 - $100.5 $47,360 - $62,611	623 Added 55.87%	1,738 $141,000
Q4 2020 Feb 02, 2021	BUY	$80.74 - $97.7 $53,853 - $65,165	667 Added 148.88%	1,115 $97,000
Q3 2020 Nov 13, 2020	BUY	$85.07 - $109.69 $36,920 - $47,605	434 Added 3100.0%	448 $40,000
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $1,038 - $1,525	14 New	14 $1,000
Q1 2020 May 13, 2020	BUY	$63.18 - $85.97 $0 - $0	0 New	0 $0
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$72.82 - $86.52 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	SELL	$73.52 - $88.7 $4,043 - $4,878	-55 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $3,495 - $4,849	55 New	55 $4,000
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $2,691 - $3,217	-46 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$61.75 - $74.23 $2,840 - $3,414	46 New	46 $3,000

Others Institutions Holding INCY

# of Institutions

703

Shares Held

189M

Call Options Held

909K

Put Options Held

447K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account

Concourse Financial Group Securities, Inc. Incyte Corp Transaction History